NYU Stern’s Endless Frontier Labs took the Prix Galien honor for Best Incubator/Accelerator, underscoring the role business schools play in translating university science into startups. The prize highlights EFL alumni launching clinical and med‑tech breakthroughs and positions Stern as a leader in mission-driven commercialization without taking equity—a model aimed at reducing early-stage uncertainty for science founders. Separately, NYU Stern’s incoming MBA Class of 2027 emphasizes New York City immersion and industry access, signaling continued demand for MBA programs that combine entrepreneurship, investor networks and hands-on pathways from campus labs to market.